Ultragenyx Pharmaceutical Inc (RARE)
40.60
-0.94
(-2.25%)
USD |
NASDAQ |
May 21, 16:00
40.60
0.00 (0.00%)
After-Hours: 17:33
Ultragenyx Pharmaceutical 1 Year Total Returns (Daily): -16.77% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 20, 2024 | -16.77% |
May 17, 2024 | -14.81% |
May 16, 2024 | -8.74% |
May 15, 2024 | -16.12% |
May 14, 2024 | -13.01% |
May 13, 2024 | -13.04% |
May 10, 2024 | -15.81% |
May 09, 2024 | -12.43% |
May 08, 2024 | -11.67% |
May 07, 2024 | -11.14% |
May 06, 2024 | -8.92% |
May 03, 2024 | -1.34% |
May 02, 2024 | 1.62% |
May 01, 2024 | -1.66% |
April 30, 2024 | -2.59% |
April 29, 2024 | 0.80% |
April 26, 2024 | 4.51% |
April 25, 2024 | 4.78% |
April 24, 2024 | 1.54% |
April 23, 2024 | 6.79% |
April 22, 2024 | 3.43% |
April 19, 2024 | 1.15% |
April 18, 2024 | 5.86% |
April 17, 2024 | 8.25% |
April 16, 2024 | 10.76% |
Date | Value |
---|---|
April 15, 2024 | 12.23% |
April 12, 2024 | 25.37% |
April 11, 2024 | 31.93% |
April 10, 2024 | 38.18% |
April 09, 2024 | 27.64% |
April 08, 2024 | 26.81% |
April 05, 2024 | 29.69% |
April 04, 2024 | 17.29% |
April 03, 2024 | 16.30% |
April 02, 2024 | 16.18% |
April 01, 2024 | 17.13% |
March 28, 2024 | 23.98% |
March 27, 2024 | 25.42% |
March 26, 2024 | 20.65% |
March 25, 2024 | 20.54% |
March 22, 2024 | 22.99% |
March 21, 2024 | 21.67% |
March 20, 2024 | 20.54% |
March 19, 2024 | 21.98% |
March 18, 2024 | 20.92% |
March 15, 2024 | 16.30% |
March 14, 2024 | 15.01% |
March 13, 2024 | 18.76% |
March 12, 2024 | 22.96% |
March 11, 2024 | 25.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-58.86%
Minimum
Nov 04 2022
298.1%
Maximum
Dec 22 2020
6.52%
Average
-14.49%
Median
Oct 20 2021
1 Year Total Returns (Daily) Benchmarks
Insulet Corp | -38.83% |
Sarepta Therapeutics Inc | -12.25% |
FibroGen Inc | -93.17% |
Apellis Pharmaceuticals Inc | -51.36% |
Amylyx Pharmaceuticals Inc | -93.11% |